NTRC Therapeutics B.V.

About NTRC Therapeutics B.V.

NTRC Therapeutics is a precision medicine company that is specialized in discovery and development of innovative kinase inhibitors to treat cancer patients. Using its proprietary EPriL platform NTRC Therapeutics is now developing next-generation kinase inhibitors to treat acquired drug resistance observed in cancer patients treated with first generation inhibitors.

Keywords

• Biotech
• Cell Panel Profiling
• Degraders
• Medicinal Chemistry
• Molecular Pharmacology
• Oncology
• Protein Crystallography
• Target Occupancy
• Target Residence Time Measurements

Address

• Headquarters

  Kloosterstraat 95349AB OssNoord-Brabant, Netherlands

Team by function

Based on 6 public job profiles as of 4 September 2026.

• Other / Unclassifiable3
• Research / R&D3